Day: November 9, 2021

SYNAPS Dx Announces DISCERN, Minimally Invasive Test for Accurate Diagnosis of Alzheimer’s Disease, Receives First-in-Category PLA Codes

ROCKVILLE, Md.--(BUSINESS WIRE)--#AlzheimersDisease--SYNAPS Dx (SDx), a privately held company focused on the research, development and commercialization of diagnostics for neurodegenerative...

error: Content is protected !!